ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,488.00
-0.25%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37725
-0.03%
Bitcoin
69,447.17
0.17%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sanofi (SNY)

  7. Sanofi (SNY) News

SNY Sanofi

48.98
-0.53 (-1.07%)
Jun 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sanofi SNY NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.53 -1.07% 48.98 19:00:00
Open Price Low Price High Price Close Price Previous Close
49.26 48.94 49.42 48.98 49.51
more quote information »

Recent News

Date Time Source Heading
6/06/202406:00PRNUSI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical..
5/31/202415:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
5/31/202400:05GLOBEDupixent® (dupilumab) Recommended for EU Approval by the..
5/31/202400:00GLOBEUpdate on FDA Priority Review of Dupixent® (dupilumab) for..
5/30/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/28/202411:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/28/202409:34EDGAR2Form SD - Specialized disclosure report
5/23/202406:40IHMARKETNEWSOpenAI and News Corp Seal Partnership, DuPont de Nemours..
5/21/202406:18IHMARKETNEWSCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils..
5/13/202400:00GLOBEDupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
5/10/202407:02IHMARKETNEWSNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple..
5/10/202401:00PRNUSNovavax and Sanofi Announce Co-exclusive Licensing Agreement..
4/25/202406:52IHMARKETNEWSSouthwest Shares Tumble 9.6% Post $231 Million 1Q Loss,..
4/19/202406:31IHMARKETNEWSParamount’s Shares Surge Following Sony and Apollo’s Joint..
2/23/202413:02EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
2/23/202410:15EDGAR2Form 20-F - Annual and transition report of foreign private..
2/15/202411:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/14/202414:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/25/202413:29GLOBEDupixent® (dupilumab) FDA Approved as First and Only..
1/23/202406:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/23/202405:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
1/23/202404:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
1/23/202400:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
1/17/202412:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/09/202401:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
12/27/202310:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202301:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
12/19/202306:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
12/12/202304:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
12/11/202316:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
12/11/202300:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
12/07/202301:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
12/07/202301:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
12/06/202307:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
12/06/202304:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
11/30/202308:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
11/30/202307:30BWTeva Completes Closing of Exclusive Collaboration Deal to..
11/27/202309:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
11/27/202301:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
11/27/202300:30GLOBEDupixent® (dupilumab) Significantly Reduced COPD..
11/07/202315:01APSOrphan Drugs Worth $64 Billion by 2028 and This Micro Cap..
11/07/202307:56DJNSanofi Under Preliminary Probe in France Over Possible..
11/07/202306:10IHMARKETNEWSTuesday’s Wall Street Highlights: WeWork, UBS, Sanofi,..
11/06/202306:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/02/202311:15PRNUSSanofi honors 10 advocacy organizations promoting health..
11/01/202307:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
11/01/202306:00PRNUSSanofi launches "The 1 Pledge" movement to drive early..
10/30/202307:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
10/27/202311:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/27/202310:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..

Your Recent History

NASDAQ
SNY
Sanofi
BIT
I06738
Intesa Sanpaolo
DGFX
MLXVUSDT
MARVELLEX VENTURES
LSE
64IO
Euro.bk.nts33
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved